Zusammenfassung
Bei der Technik der intraaortalen Gegenpulsation (IABP) handelt es sich um die einfachste invasive Form der mechanischen Kreislaufunterstützung (MKU). Eine IABP ist in nahezu allen kardiologischen und kardiochirurgischen Kliniken verfügbar, sie ist schnell bettseitig einsetzbar, effektiv, verhältnismäßig kostengünstig und ein komplikationsarmes Verfahren.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Literatur zu 3.1
Briguori C, Sarais C, Pagnotta P, Airoldi F, Liistro F et al (2003) Elective versus provisional intraaortic balloon pumping in high-risk percutanous transluminal coronary angioplasty. Am Heart J 145: 700-707
Christenson JT, Simonet F, Badel P, Schmuziger M (1999) Optimal timing of preoperative intraaortic balloon pump support in high-risk coronary patients. Ann Thorac Surg 68: 934-939
Collison SP, Dagar KS (2007) The role of intraaortic balloon pump in supporting children with acute cardiac failure. Postgrad Med J 83: 308-311
Craver JM, Murrah CP (2001) Elective intraaortic balloon counterpulsation for high-risk off-pump coronary artery bypass operations. Ann Thorac Surg 71: 1220-1223
Erdogan HB, Goksedef D, Erentug V et al (2006) In which patients should sheathless IABP be used? An analysis of vascular complications in 1211 cases. J Cardiovasc Surg 21(4): 342-346
Ferguson JJ 3rd, Cohen M, Freedman RJ Jr et al (2001) The current practice of intra-aortic balloon counterpulsation: Results from the Benchmark Registry. J Am Coll Cardiol 38(5): 1456-1462
Fuchs RM, Brin KP, Brinker JA, Guzman PA, Heuser RR, Yin FC (1983) Augmentation of coronary blood flow by intraaortic balloon counterpulsation in patients with unstable angina. Circulation 68: 117-123
Harken DE (1976) Counterpulsation. Med Instrum 10(5): 215
Hochman JS, Boland J, Sleeper LA, Porway M, Brinker J et al for SHOCK Registry Investigators (1995) Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an international registry. Circulation 91: 873-881
Kantrowitz A (1953) Experimental augmentation of coronary flow by retardation of the arterial pressure pulse. Surgery 34(4): 678-687
Kantrowitz A, Tjonneland S, Freed PS et al (1968) Initial clinical experience with intraaortic balloon pumping in cardiogenic shock. JAMA 203(2): 113-118
Lindsay AC, Khaghani A, Dalby MCD (2009) Intra-aortic balloon and other counterpulsation techniques In: ISHLT Monograph Series 3, Advanced Heart Failure, Elsevier, Philadelphia London, Toronto Montreal Sydney Tokyo, S 557-568
Marcu CB, Donohue TJ, Ferneini A, Ghantous AE (2006) Intraaortic balloon pump insertion through the subclavian artery. Subclavian artery insertion of IABP Heart Lung Circ 15(2): 148-150
Moulopoulos SD, Topaz S, Kolff WJ (1962) Diastolic balloon pumping (with carbon dioxide) in the aorta- a mechanical assistance to the failing circulation. Am Heart J 63: 669-675
Ohman EM, Califf RM, George BS, Quigley PJ, Kereiakes DJ et al for the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group (1991) The use of intraaortic balloon pumping as an adjunct to reperfusion therapy in acute myocardial infarction. Am Heart J 121(3Pt1): 895-901
Onorati F, Impiombato B, Ferraro A, Comi MC, Spaccarotella C et al (2007) Transbrachial intraaortic balloon pumping in severe peripheral atherosclerosis. Ann Thorac Surg 84(1): 264-266
Santini F, Mazzucco A (1997) Transthoracic intraaortic counterpulsation: A simple method for ballon catheter positioning. Ann Thorac Surg 64: 859-860
Stone G, Marsalese D, Brodie B, Griffin J, Donohue B et al (1995a) The routine of intra aortic balloon after primary PTCA improves clinical outcomes in very high-risk patients with acute myocardial infarction: Results of the PAMI-2 Trial (abstract). Circulation 92(I): 139
Stone G, Marsalese D, Brodie B, Griffin J, Donohue B et al (1995b) Is prophylactic IABP use beneficial or harmful in a high risk elderly population with acute myocardial infarction? Results of the PAMI-2 trial (abstract). Circulation 92(I): 139
Literatur zu 3.2
Alasnag MA, Gardi DO, Elder M, Kannam H, Ali F et al (2011) Use of the Impella 2.5 for prophylactic circulatory support during elective high-risk percutaneous coronary intervention. Cardiovasc Revasc Med 12(5): 299-303
Alli OO, Singh IM, Holmes DR, Jr., Pulido JN, Park SJ, Rihal CS (2012) Percutaneous left ventricular assist device with TandemHeart for high-risk percutaneous coronary intervention: The mayo clinic experience. Catheter Cardiovasc Interv 2012 Feb 29. doi: 10.1002/ccd.23465. [Epub ahead of print]
Amico A, Brigiani MS, Vallabini A, Ferrante B, Marzovillo A et al (2008) a new short-term ventricular assist device: our experience in off-pump coronary artery bypass graft surgery. J Cardiovasc Med (Hagerstown) 9(4): 423-426.
Anastasiadis K, Chalvatzoulis O, Antonitsis P, Tossios P, Papakonstantinou C (2011) Left ventricular decompression during peripheral extracorporeal membrane oxygenation support with the use of the novel iVAC pulsatile paracorporeal assist device. Ann Thorac Surg 92(6): 2257-2259
Basra SS, Loyalka P, Kar B (2011) Current status of percutaneous ventricular assist devices for cardiogenic shock. Curr Opin Cardiol 26(6): 548-554
Burkhoff D, Cohen H, Brunckhorst C, O’Neill WW (2006) A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J 152(3): 469-468
Dixon SR, Henriques JP, Mauri L, Sjauw K, Civitello A et al (2009) A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience. JACC Cardiovasc Interv 2(2): 91-96
Froesch P, Martinelli M, Meier P, Cook S, Hullin R, et al (2011) Clinical use of temporary percutaneous left ventricular assist devices. Catheter Cardiovasc Interv 78(2): 304-313
Higgins J, Lamarche Y, Kaan A, Stevens LM, Cheung A (2011) Microaxial devices for ventricular failure: a multicentre, population-based experience. Can J Cardiol 27(6): 725-730.
Kovacic JC, Nguyen HT, Karajgikar R, Sharma SK, Kini AS (2011) The impella recover 2.5 and TandemHeart ventricular assist devices are safe and associated with equivalent clinical outcomes in patients undergoing high-risk percutaneous coronary intervention. Catheter Cardiovasc Interv 2011 Jan 13 [Epub ahead of print]
Maini B, Naidu SS, Mulukutla S, Kleiman N, Schreiber T et al (2011) Real-world use of the impella 2.5 circulatory support system in complex high-risk percutaneous coronary intervention: The uspella registry. Catheter Cardiovasc Interv 2011 Nov 22. doi: 10.1002/ccd.23403. [Epub ahead of print]
Samuels LE, Kaufman MS, Thomas MP, Holmes EC, Brockman SK, Wechsler AS (1999) Pharmacological criteria for ventricular assist device insertion following postcardiotomy shock: experience with the Abiomed BVS system. J Card Surg 14(4): 288-293
Schwartz BG, Ludeman DJ, Mayeda GS, Kloner RA, Economides C, Burstein S. (2011) High-risk percutaneous coronary intervention with the TandemHeart and Impella devices: a single-center experience. J Invasive Cardiol 23(10): 417-424
Seyfarth M, Sibbing D, Bauer I, Frohlich G, Bott-Flugel L et al (2008) A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intraaortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol 52(19): 1584-1588
Siegenthaler MP, Brehm K, Strecker T, Hanke T, Notzold A et al (2004) The Impella Recover microaxial left ventricular assist device reduces mortality for postcardiotomy failure: a three-center experience. J Thorac Cardiovasc Surg 127(3): 812-822
Tempelhof MW, Klein L, Cotts WG, Benzuly KH, Davidson CJ et al (2011) Clinical experience and patient outcomes associated with the TandemHeart percutaneous transseptal assist device among a heterogeneous patient population. ASAIO J 57(4): 254-261
Thiele H, Lauer B, Hambrecht R, Boudriot E, Cohen HA, Schuler G. (2001) Reversal of cardiogenic shock by percutaneous left atrial-to-femoral arterial bypass assistance. Circulation 104(24): 2917-2922
Literatur zu 3.3
Arlt M, Philipp A, Voelkel S, Camboni D, Rupprecht L et al (2011) Hand-held minimised extracorporeal membrane oxygenation: a new bridge to recovery in patients with out-of-centre cardiogenic shock. Eur J Cardiothorac Surg 40(3): 689-694
Arlt M, Philipp A, Voelkel S, Graf BM, Schmid C, Hilker M (2011) Out-of-hospital extracorporeal life support for cardiac arrest-A case report. Resuscitation 82(9): 1243-1245
Arlt M, Philipp A, Zimmermann M, Voelkel S, Amann M et al (2009) Emergency Use of Extracorporeal Membrane Oxygenation in Cardiopulmonary Failure. Artifi Org 33(9): 696-703
Beurtheret S, Mordant P, Paoletti X, Marijon E, Celermajer DS et al (2012) Emergency circulatory support in refractory cardiogenic shock patients in remote institutions: a pilot study (the cardiac-RESCUE program), Eur Heart J 2012, Apr. 17. [Epub ahead of print]
Chen YS, Lin JW, Yu HY, Ko WJ, Jerng JS et al (2008) Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: an observational study and propensity analysis. Lancet 372(9638): 554-561
Chen YS, Yu HY, Huang SC, Lin JW et al (2008) Extracorporeal membrane oxygenation support can extend the duration of cardiopulmonary resuscitation. Crit Care Med 36: 2529-2535
Combes A, Leprince P, Luyt CE, Bonnet N, Trouillet JL et al (2008) Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock: Crit Care Med 36: 1404-1411
Le Guen M, Nicolas-Robin A, Carreira S, Raux M, Leprince P et al (2011) Extracorporeal life support following out-of-hospital refractory cardiac arrest, Critical Care 15: R29
Lin JW, Wang MJ, Yu HY, Wang CH, Chang WT et al (2010) Comparing the survival between extracorporeal rescue and conventional resuscitation in adult in-hospital cardiac arrests: Propensity analysis of three-year data. Resuscitation 81(7): 796-803
Massetti M, Tasle M, Le Page O, Deredec R, Babatasi G et al (2005) Back from Irreversibility: Extracorporeal Life Support for Prolonged Cardiac Arrest. Ann Thorac Surg 79: 178-183
Peek GJ (2011) Community extracorporeal life support for cardiac arrest - When should it be used? Resuscitation 82: 1117 editorial
Ranucci M, Ballotta A, Kandil H, Isgrö G, Carlucci C et al for the Surgical and Clinical Outcome Research Group (2011) Bivalirudin-based versus conventional heparin anticoagulation for postcardiotomy extracorporeal membrane oxygenation. Critical Care 15: R275
Thiagarajan RR, Brogan TV, Scheurer MA, Laussen PC, Rycus PT, Bratton SL (2009) Extracorporeal Membrane Oxygenation to Support Cardiopulmonary Resuscitation in Adults. Ann Thorac Surg 87:778-85
Literatur zu 3.4
Chen et al (2009) CPR vs ECPR for in hospital Cardiac Arrset (Taiwan) Lancet
Coppola CP, Tyreeb M, Larryb K, Di Geronimob R (2008) A 22-year experience in global transport extracorporeal membrane oxygenation. J Ped Surg 43, 46-52
Nichol G, Thomas E, Callaway CW et al (2008) Regional Variation in Out-of-Hospital Cardiac Arrest Incidence and Outcome, Jama 300(12)1423-1431 EASA, www.easa.europa.eu
Bartlett R, Gattinoni L (2010) Current status of extracorporeal life support (ECMO) for cardiopulmonary failure. Minerva Anestesiol 76 (7): 534-540
Schmid C, Philipp A, Müller T, Hilker M (2009) Extracorporeal Life Support Systems, Indications and Limitations. Thorac Cardiovasc Surg 57: 449-454
Bisdas T, Beutel G, Warnecke G et al (2011) Vascular complications in patients undergoing femoral cannulation for extracorporeal membrane oxygenation support. Ann Thorac Surg 92(2):626-631, Epub 2011 May 8
Berdajs D, Born F, Crosset M et al (2010) Superior venous drainage in the „Life Box»: a portable extracorporeal oxygenator with a self-expanding venous cannula. Perfusion 25: 211-215 http://www.elso.med.umich.edu/
Güngerich A,(2010) Ein Herz will weiterschlagen. 1414 Gönnermagazin der Schweizerischen Rettungsflugwacht 74: 12-13
Born F, Ammann U, Burren T, Albrecht R et al (2010) Transatlantikflug mit transportabler HerzLungen-Maschine «LifeBox«, Kardiotechnik (3): 65-69
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Boeken, U., Assmann, A., Born, F., Schmid, C. (2013). Akuttherapie. In: Boeken, U., Assmann, A., Born, F., Schmid, C. (eds) Mechanische Herz-Kreislauf-Unterstützung. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-29408-2_3
Download citation
DOI: https://doi.org/10.1007/978-3-642-29408-2_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-29407-5
Online ISBN: 978-3-642-29408-2
eBook Packages: Medicine (German Language)